First-in-class biologic to enter rheumatoid arthritis fray.
Garber
Ken
K
D000069594:Abatacept; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000639:trends; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D007167:Immunotherapy / Q000379:methods; D018124:Receptors, Tumor Necrosis Factor / Q000737:chemistry; D014409:Tumor Necrosis Factor-alpha / Q000737:chemistry
D018501:Antirheumatic Agents; D018796:Immunoconjugates; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069594:Abatacept